ATE69891T1 - Monoklonalantikoerperabfassung fuer diagnostischen gebrauch. - Google Patents

Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.

Info

Publication number
ATE69891T1
ATE69891T1 AT84850009T AT84850009T ATE69891T1 AT E69891 T1 ATE69891 T1 AT E69891T1 AT 84850009 T AT84850009 T AT 84850009T AT 84850009 T AT84850009 T AT 84850009T AT E69891 T1 ATE69891 T1 AT E69891T1
Authority
AT
Austria
Prior art keywords
draft
monoclonal antibody
diagnostic use
formulation containing
antigens
Prior art date
Application number
AT84850009T
Other languages
English (en)
Inventor
Karl Arne Lundblad
Original Assignee
Monocarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20349708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE69891(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monocarb Ab filed Critical Monocarb Ab
Application granted granted Critical
Publication of ATE69891T1 publication Critical patent/ATE69891T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT84850009T 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch. ATE69891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8300320A SE434680B (sv) 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
EP84850009A EP0115476B1 (de) 1983-01-21 1984-01-10 Monoklonalantikörperabfassung für diagnostischen Gebrauch

Publications (1)

Publication Number Publication Date
ATE69891T1 true ATE69891T1 (de) 1991-12-15

Family

ID=20349708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84850009T ATE69891T1 (de) 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.

Country Status (6)

Country Link
US (1) US4618486A (de)
EP (1) EP0115476B1 (de)
JP (1) JPH0654316B2 (de)
AT (1) ATE69891T1 (de)
DE (1) DE3485289D1 (de)
SE (1) SE434680B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764465A (en) * 1984-04-26 1988-08-16 Cetus Corporation Human monoclonal antibody against group A red blood cells
EP0223978B1 (de) * 1985-10-11 1992-08-19 Abbott Laboratories Diagnostische Probe
US4695553A (en) * 1985-11-01 1987-09-22 Becton Dickinson And Co., Inc. Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
DE4035174A1 (de) * 1990-11-06 1992-05-07 Biotest Ag Verfahren zur bestimmung von proteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens
US20030113316A1 (en) * 2001-07-25 2003-06-19 Kaisheva Elizabet A. Stable lyophilized pharmaceutical formulation of IgG antibodies
AU2003291689A1 (en) * 2002-10-31 2004-05-25 Protein Design Labs, Inc. Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
JP4934426B2 (ja) 2003-08-18 2012-05-16 メディミューン，エルエルシー 抗体のヒト化
EP1765987A4 (de) * 2004-06-11 2008-05-07 Kiwi Ingenuity Ltd Enzymatische modifikation von zelloberflächenantigen h durch glykosyltransferasen
EP1869192B1 (de) 2005-03-18 2016-01-20 MedImmune, LLC Rahmenmischung von antikörpern
US20070110757A1 (en) 2005-06-23 2007-05-17 Ziping Wei Antibody formulations having optimized aggregation and fragmentation profiles
WO2011029823A1 (en) 2009-09-09 2011-03-17 Novartis Ag Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
EP2625203A1 (de) 2010-10-05 2013-08-14 Novartis AG Anti-il12rbeta1-antikörper und ihre verwendung zur behanldung von autoimmun- und entzündungserkrankungen
MA38322B1 (fr) 2013-02-08 2018-09-28 Novartis Ag Anticorps anti-il-17a et leur utilisation dans le traitement de troubles auto-immuns et inflammatoires
EP3161001A2 (de) 2014-06-25 2017-05-03 Novartis AG Il17-a spezifische antikörper die mit hyaluronan bindenden peptid-marker fusioniert sind
CA3009001A1 (en) 2016-01-11 2017-07-20 Universitat Zurich Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof
US11773160B1 (en) 2022-08-05 2023-10-03 Anaveon AG Immune-stimulating IL-2 fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164558A (en) * 1976-11-22 1979-08-14 Massachusetts Institute Of Technology Method for optimizing reagents for agglutination reactions
US4319882A (en) * 1980-02-21 1982-03-16 Yash Sharma Method for detecting immunological agglutination and biochemical agent therefor
JPS58500366A (ja) * 1981-03-06 1983-03-10 セルテツク　リミテツド 単一クロ−ン抗体
EP0061541A1 (de) * 1981-03-27 1982-10-06 Biospecia Limited Immunologische Analyse und biochemisches Mittel hierfür
WO1982003462A1 (en) * 1981-03-27 1982-10-14 Ltd Biospecia Immunological analysis and a biochemical agent therefore
GB2117789B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Abo blood grouping reagent
GB2127434A (en) * 1982-09-17 1984-04-11 Univ London A human monoclonal antibody against Rhesus D antigen

Also Published As

Publication number Publication date
DE3485289D1 (de) 1992-01-09
JPH0654316B2 (ja) 1994-07-20
SE8300320L (sv) 1984-07-22
JPS59138959A (ja) 1984-08-09
EP0115476B1 (de) 1991-11-27
EP0115476A3 (en) 1988-10-12
SE434680B (sv) 1984-08-06
SE8300320D0 (sv) 1983-01-21
US4618486A (en) 1986-10-21
EP0115476A2 (de) 1984-08-08

Similar Documents

Publication Publication Date Title
ATE69891T1 (de) Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
EP0420913A4 (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
AU498364B2 (en) Assaying antibody, antigen or antibody-antigen complex in fluid sample
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
ES445768A1 (es) Metodo de preparacion de un reactivo en fase solida para usoen el radio inmunoensayo de antigenos y anticuerpos y de realizacon del radio inmunoensayo.
NO965239D0 (no) Monoklonalt antistoff mot CD44v6
CA2025607A1 (en) Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents
ATE50868T1 (de) Ultraschall-beschleunigte immuno-reaktionen.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
IT8820741A0 (it) Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori.
ES444543A1 (es) Metodo de determinacion inmunologica.
EP0131627A4 (de) Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikörper und verfahren zu ihrer verwendung.
EP0109434A4 (de) In vitro diagnoseverfahren unter verwendung von monoklonalen antikörpern gegen konnektive gewebeproteine.
EP0522169A4 (en) Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay
ES457714A1 (es) Procedimiento para el enriquecimiento de la proteina ep5 es-pecifica de la placenta.
KR950702207A (ko) Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them)
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
OA08782A (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
IL55564A (en) Method for the quantitative determination of antigens in aqueous solutions
FR2376864A1 (fr) Reactif et procede de determination du cholecalciferol
SU1163864A1 (ru) Способ определени антиэритроцитарных антител

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties